Works matching IS 14642662 AND DT 2006 AND VI 7 AND IP 2

Results: 9

A prospective, 96-week study of the impact of TRIZIVIR, COMBIVIR/nelfinavir, and lamivudine/stavudine/nelfinavir on lipids, metabolic parameters and efficacy in antiretroviral-naive patients: effect of sex and ethnicity.

Published in:

2006

By:

Kumar PN;
Rodriguez-French A;
Thompson MA;
Tashima KT;
Averitt D;
Wannamaker PG;
Williams VC;
Shaefer MS;
Pakes GE;
Pappa KA;
ESS40002 Study Team

Publication type:

Journal Article

nef gene sequence variation among HIV-1-infected African children.

Published in:

HIV Medicine, 2006, v. 7, n. 2, p. 75, doi. 10.1111/j.1468-1293.2006.00341.x

By:

Chakraborty, R.;
Reinis, M.;
Rostron, T.;
Philpott, S.;
Dong, T.;
D'Agostino, A.;
Musoke, R.;
de Silva, E.;
Stumpf, M.;
Weiser, B.;
Burger, H.;
Rowland-Jones, S. L.

Publication type:

Article

A prospective, 96-week study of the impact of Trizivir<sup>®</sup>, Combivir<sup>®</sup>/nelfinavir, and lamivudine/stavudine/nelfinavir on lipids, metabolic parameters and efficacy in antiretroviral-naive patients: effect of sex and ethnicity.

Published in:

HIV Medicine, 2006, v. 7, n. 2, p. 85, doi. 10.1111/j.1468-1293.2006.00346.x

By:

Kumar, P. N.;
Rodriguez-French, A.;
Thompson, M. A.;
Tashima, K. T.;
Averitt, D.;
Wannamaker, P. G.;
Williams, V. C.;
Shaefer, M. S.;
Pakes, G. E.;
Pappa, K. A.

Publication type:

Article

Immunological and virological responses to highly active antiretroviral therapy in a non-clinical trial setting in a developing Caribbean country.

Published in:

HIV Medicine, 2006, v. 7, n. 2, p. 99, doi. 10.1111/j.1468-1293.2006.00347.x

By:

Kilaru, K. R.;
Kumar, A.;
Sippy, N.;
Carter, A. O.;
Roach, T. C.

Publication type:

Article

HIV-related neutropaenia exacerbated by efavirenz.

Published in:

HIV Medicine, 2006, v. 7, n. 2, p. 129, doi. 10.1111/j.1468-1293.2006.00348.x

By:

Healy, B. J.;
Freedman, A. R.

Publication type:

Article

Minor changes in calculated creatinine clearance and anion-gap are associated with tenofovir disoproxil fumarate-containing highly active antiretroviral therapy.

Published in:

HIV Medicine, 2006, v. 7, n. 2, p. 105, doi. 10.1111/j.1468-1293.2006.00349.x

By:

Winston, A.;
Amin, J.;
Mallon, P. W. G.;
Marriott, D.;
Carr, A.;
Cooper, D. A.;
Emery, S.

Publication type:

Article

Depression and neurocognitive performance in individuals with HIV/AIDS: 2-year follow-up.

Published in:

HIV Medicine, 2006, v. 7, n. 2, p. 112, doi. 10.1111/j.1468-1293.2006.00350.x

By:

Gibbie, T.;
Mijch, A.;
Ellen, S.;
Hoy, J.;
Hutchison, C.;
Wright, E.;
Chua, P.;
Judd, F.

Publication type:

Article

Analysis of genotypic and phenotypic clinical cut-off levels for ritonavir-boosted saquinavir.

Published in:

HIV Medicine, 2006, v. 7, n. 2, p. 67, doi. 10.1111/j.1468-1293.2006.00351.x

By:

Hill, A.;
Walmsley, S.;
Clotet, B.;
Molto, J.

Publication type:

Article

Characterization of nelfinavir binding to plasma proteins and the lack of drug displacement interactions.

Published in:

HIV Medicine, 2006, v. 7, n. 2, p. 122, doi. 10.1111/j.1468-1293.2006.00356.x

By:

Motoya, T.;
Thevanayagam, L. N.;
Blaschke, T. F.;
Au, S.;
Stone, J. A.;
Jayewardene, A. L.;
Chi, J.;
Aweeka, F. T.

Publication type:

Article